Kingworld Medicines Group Ltd. (HK:1110) has released an update.
Kingworld Medicines Group Ltd. has announced its Board of Directors as of September 1, 2024, which includes both executive and independent non-executive members. The board comprises seven individuals with Mr. Zhao Li Sheng as the Chairman and roles distributed across three key committees: Audit, Remuneration, and Nomination. This restructuring reflects Kingworld’s commitment to strong governance and oversight in its operations.
For further insights into HK:1110 stock, check out TipRanks’ Stock Analysis page.
